Radiolabeled peptides targeted against receptors on the cell surface have been shown to
be remarkably specific and effective in the diagnosis and therapy of malignant disease …

Somatostatin receptors are useful drug targets for therapy aimed at the treatment of humoral
effects of certain tumors. Radiolabeled somatostatin analogs, such as octreotide, with a high …

The authors briefly review radiopeptides currently approved for use in the United States.
They present a short review of the peptide somatostatin's actions and also note the five …

On their plasma membranes, cells express receptor proteins with high affinity for regulatory
peptides, such as somatostatin. Changes in the density of these receptors during disease …

This article reviews the results of somatostatin receptor imaging (SRI) in patients with
somatostatin receptor–positive neuroendocrine tumors, such as pituitary tumors, endocrine …

[en] On their plasma membranes, cells express receptor proteins with high affinity for
regulatory peptides, such as somatostatin. Changes in the density of these receptors during …

On their plasma membranes, cells express receptor proteins with high affinity for regulatory
peptides, such as somatostatin. Changes in the density of these receptors during disease …

Receptors for regulatory peptides are overexpressed in a variety of human cancers. They
represent the molecular basis for in vivo imaging with radiolabeled peptide probes …

Regulatory peptides are small, readily diffusable and potent natural substances with a wide
spectrum of receptor-mediated actions in humans. High affinity receptors for these peptides …

Molecular imaging plays an essential role in balancing the clinical benefits and risks of
radionuclide-based cancer therapy. To effectively treat individual patients, careful …